FDA Finalizes Board Member Conflict Of Interest Policies
Aiming to shore up its conflict of interest policies, the U.S. Food and Drug Administration on Monday finalized policies for publicly disclosing the financial ties of advisory board members whose votes...To view the full article, register now.
Already a subscriber? Click here to view full article